- Home
- Publications
- Publication Search
- Publication Details
Title
Pharmacokinetics and pharmacodynamics of peptide antibiotics
Authors
Keywords
Antimicrobial resistance, Antimicrobial peptide, Antibiotics, Pharmacokinetics, Pharmacodynamics, Safety, Therapeutic drug monitoring
Journal
ADVANCED DRUG DELIVERY REVIEWS
Volume -, Issue -, Pages 114171
Publisher
Elsevier BV
Online
2022-02-19
DOI
10.1016/j.addr.2022.114171
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Pharmacokinetic/Pharmacodynamic Based Breakpoints of Polymyxin B for Bloodstream Infections Caused by Multidrug-Resistant Gram-Negative Pathogens
- (2022) Xingchen Bian et al. Frontiers in Pharmacology
- Acute toxicity is a dose-limiting factor for intravenous polymyxin B: A safety and pharmacokinetic study in healthy Chinese subjects
- (2021) Xiaofen Liu et al. JOURNAL OF INFECTION
- Effects of Different Component Contents of Colistin Methanesulfonate on the Pharmacokinetics of Prodrug and Formed Colistin in Human
- (2021) Ya-Xin Fan et al. PHARMACEUTICAL RESEARCH
- Rescuing the Last-Line Polymyxins: Achievements and Challenges
- (2021) Sue C. Nang et al. PHARMACOLOGICAL REVIEWS
- Impact on Antibiotic Resistance, Therapeutic Success, and Control of Side Effects in Therapeutic Drug Monitoring (TDM) of Daptomycin: A Scoping Review
- (2021) Carolina Osorio et al. Antibiotics-Basel
- Multi-step vs. single-step resistance evolution under different drugs, pharmacokinetics and treatment regimens
- (2021) Claudia Igler et al. eLife
- Modeling Approach to Optimizing Dose Regimen of Vancomycin for Chinese Pediatric Patients with Gram-Positive Bacterial Infections
- (2021) Kai Shen et al. Frontiers in Pharmacology
- Single- and Multiple-Ascending-Dose Study of the Safety, Tolerability, and Pharmacokinetics of the Polymyxin Derivative SPR206
- (2021) Jon Bruss et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- An Update on Population Pharmacokinetic Analyses of Vancomycin, Part I: In Adults
- (2020) Abdullah Aljutayli et al. CLINICAL PHARMACOKINETICS
- Molecular mechanisms of vancomycin resistance
- (2020) Peter J. Stogios et al. PROTEIN SCIENCE
- Therapeutic monitoring of vancomycin for serious methicillin-resistant Staphylococcus aureus infections: A revised consensus guideline and review by the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists
- (2020) Michael J Rybak et al. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
- Intrathecal Antibacterial and Antifungal Therapies
- (2020) Roland Nau et al. CLINICAL MICROBIOLOGY REVIEWS
- Antimicrobial therapeutic drug monitoring in critically ill adult patients: a Position Paper#
- (2020) Mohd H. Abdul-Aziz et al. INTENSIVE CARE MEDICINE
- Ca2+-Daptomycin targets cell wall biosynthesis by forming a tripartite complex with undecaprenyl-coupled intermediates and membrane lipids
- (2020) Fabian Grein et al. Nature Communications
- VanZ Reduces the Binding of Lipoglycopeptide Antibiotics to Staphylococcus aureus and Streptococcus pneumoniae Cells
- (2020) Vladimir Vimberg et al. Frontiers in Microbiology
- Polymyxin-induced cell death of human macrophage-like THP-1 and neutrophil-like HL-60 cells associated with the activation of apoptotic pathways
- (2020) Ahmed M. Fathalla et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Single-nucleotide polymorphisms in a vancomycin-resistant Staphylococcus aureus strain based on whole-genome sequencing
- (2020) Jung Wook Kim et al. ARCHIVES OF MICROBIOLOGY
- Emergence of vancomycin- and teicoplanin-resistant Enterococcus faecium via vanD5-harbouring large genomic island
- (2020) Toyotaka Sato et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Population Pharmacokinetics and Limited Sampling Strategy for Therapeutic Drug Monitoring of Polymyxin B in Chinese Patients With Multidrug-Resistant Gram-Negative Bacterial Infections
- (2020) Peile Wang et al. Frontiers in Pharmacology
- A Systematic Review of Vancomycin Dosing in Patients with Hematologic Malignancies or Neutropenia
- (2020) Na He et al. Infection and Drug Resistance
- Clinical Experience with High-Dose Polymyxin B against Carbapenem-Resistant Gram-Negative Bacterial Infections—A Cohort Study
- (2020) Yiying Cai et al. Antibiotics-Basel
- Pharmacodynamic Evaluation of MRX-8, a Novel Polymyxin, in the Neutropenic Mouse Thigh and Lung Infection Models against Gram-Negative Pathogens
- (2020) Alexander J. Lepak et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Population pharmacokinetic and optimization of polymyxin B dosing in adult patients with various renal function
- (2020) Xu‐Ben Yu et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Estimation of the area under concentration-time curve of polymyxin B based on limited sampling concentrations in Chinese patients with severe pneumonia
- (2020) Wenqian Chen et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Antimicrobial Peptides: Classification, Design, Application and Research Progress in Multiple Fields
- (2020) Yuchen Huan et al. Frontiers in Microbiology
- A Clinical Study on the Use of Intraventricular Polymyxin B Supplemented by Continuous External Ventricular Drainage in the Treatment of Drug-Resistant Gram-Negative Bacilli Intracranial Infection
- (2020) Hongwei Chen et al. Infection and Drug Resistance
- Antibiotics Differentially Modulate Lipoteichoic Acid-Mediated Host Immune Response
- (2020) Marquerita Algorri et al. Antibiotics-Basel
- Does renal function matter for polymyxin B?
- (2020) Sean N. Avedissian et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Evidence-based Guideline for Therapeutic Drug Monitoring of Vancomycin: 2020 Update by the Division of Therapeutic Drug Monitoring, Chinese Pharmacological Society
- (2020) Na He et al. CLINICAL INFECTIOUS DISEASES
- Alternative vanHAX promoters and increased vanA-plasmid copy number resurrect silenced glycopeptide resistance in Enterococcus faecium
- (2020) Theresa Maria Wagner et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Population Pharmacokinetics and Model-Based Dosing Optimization of Teicoplanin in Pediatric Patients
- (2020) Tao Zhang et al. Frontiers in Pharmacology
- Pharmacokinetic/pharmacodynamic evaluation of teicoplanin against Staphylococcus aureus in murine thigh infection model
- (2020) Erika Watanabe et al. Journal of Global Antimicrobial Resistance
- Multidrug-Resistant Bacteria and Alternative Methods to Control Them: An Overview
- (2019) Roberto Vivas et al. Microbial Drug Resistance
- Vancomycin Area under the Curve and Acute Kidney Injury: A Meta-analysis
- (2019) Doaa M Aljefri et al. CLINICAL INFECTIOUS DISEASES
- Readiness to implement vancomycin monitoring based on area under the concentration–time curve: A cross-sectional survey of a national health consortium
- (2019) Wesley D Kufel et al. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
- Recent Advances in the Exploration of Therapeutic Analogues of Gramicidin S, an Old but Still Potent Antimicrobial Peptide
- (2019) Qinkun Guan et al. JOURNAL OF MEDICINAL CHEMISTRY
- Multifunctional Pharmaceutical Effects of the Antibiotic Daptomycin
- (2019) Yang Ye et al. Biomed Research International
- Polymyxins and Their Potential Next Generation as Therapeutic Antibiotics
- (2019) Martti Vaara Frontiers in Microbiology
- Vancomycin is commonly under‐dosed in critically ill children and neonates
- (2019) Natasha Sosnin et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Renaissance of Vancomycin: Approaches for Breaking Antibiotic-Resistance in Multidrug-Resistant Bacteria
- (2019) Eric Mühlberg et al. CANADIAN JOURNAL OF MICROBIOLOGY
- Colistin for the treatment of urinary tract infections caused by extremely drug-resistant Pseudomonas aeruginosa: Dose is critical
- (2019) Luisa Sorlí et al. JOURNAL OF INFECTION
- Emergent Polymyxin Resistance: End of an Era?
- (2019) Zekun Li et al. Open Forum Infectious Diseases
- The clinical efficacy and safety of vancomycin loading dose
- (2019) Hekun Mei et al. MEDICINE
- Long-term vancomycin use had low risk of ototoxicity
- (2019) Clayton Humphrey et al. PLoS One
- Integrated evolutionary analysis reveals antimicrobial peptides with limited resistance
- (2019) Réka Spohn et al. Nature Communications
- Personalizing Polymyxin B Dosing Using an Adaptive Feedback Control Algorithm
- (2018) Elizabeth A. Lakota et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Population Pharmacokinetics of Polymyxin B
- (2018) Pooja Manchandani et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Detection of colistin heteroresistance in Acinetobacter baumannii from blood and respiratory isolates
- (2018) Pavithra Srinivas et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Impact of cefazolin co-administration with vancomycin to reduce development of vancomycin-intermediate Staphylococcus aureus
- (2018) Nivedita B. Singh et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Population pharmacokinetics of daptomycin in critically ill patients
- (2018) A. Soraluce et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Polymyxins for CNS infections: Pharmacology and neurotoxicity
- (2018) Tony Velkov et al. PHARMACOLOGY & THERAPEUTICS
- Polymyxin B Pharmacokinetics in Adult Cystic Fibrosis Patients
- (2018) Sean N. Avedissian et al. PHARMACOTHERAPY
- Sputum Active Polymyxin Lipopeptides: Activity against Cystic Fibrosis Pseudomonas aeruginosa Isolates and Their Interactions with Sputum Biomolecules
- (2018) Elena K. Schneider-Futschik et al. ACS Infectious Diseases
- Polymyxin B-induced skin hyperpigmentation: a rare case report and literature review
- (2018) Guanhao Zheng et al. BMC Pharmacology & Toxicology
- Changing Priorities in Vaccinology: Antibiotic Resistance Moving to the Top
- (2018) Aldo Tagliabue et al. Frontiers in Immunology
- Renal Dosing of Antibiotics: Are We Jumping the Gun?
- (2018) Ryan L Crass et al. CLINICAL INFECTIOUS DISEASES
- Implementation of a two-point pharmacokinetic AUC-based vancomycin therapeutic drug monitoring approach in patients with methicillin-resistant Staphylococcus aureus bacteremia
- (2018) Bryan T. Mogle et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Current use of daptomycin and systematic therapeutic drug monitoring: clinical experience in a tertiary care institution
- (2018) Alicia Galar et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Simple LC-MS/MS Methods Using Core-Shell ODS Microparticulate for the Quantitation of Total and Free Daptomycin in Human Plasma
- (2018) Yukari Miyadera et al. THERAPEUTIC DRUG MONITORING
- Optimal infusion rate in antimicrobial therapy: explosion of evidence in the last five years
- (2018) Ling-ling Zhu et al. Infection and Drug Resistance
- Making the change to area under the curve–based vancomycin dosing
- (2018) Emily L. Heil et al. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
- Nephrotoxicity prevalence in patients treated with polymyxins: a systematic review with meta-analysis of observational studies
- (2018) Ana F. Oliota et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- A Short Communication
- (2018) Eun Jung Kim et al. THERAPEUTIC DRUG MONITORING
- CSF penetration of vancomycin in critical care patients with proven or suspected ventriculitis: a prospective observational study
- (2018) Ute Blassmann et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Colistin versus polymyxin B for the treatment of patients with multidrug-resistant Gram-negative infections: a systematic review and meta-analysis
- (2017) Konstantinos Z. Vardakas et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Pharmacodynamics of teicoplanin against MRSA
- (2017) V Ramos-Martín et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Population pharmacokinetics of total and unbound teicoplanin concentrations and dosing simulations in patients with haematological malignancy
- (2017) Catherine J Byrne et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Daptomycin
- (2017) Mohsen Heidary et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Population pharmacokinetics of teicoplanin administered by subcutaneous or intravenous route and simulation of optimal loading dose regimen
- (2017) Yoann Cazaubon et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Minocycline attenuates colistin-induced neurotoxicity via suppression of apoptosis, mitochondrial dysfunction and oxidative stress
- (2017) Chongshan Dai et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Population pharmacokinetics and dosing considerations for the use of daptomycin in adult patients with haematological malignancies
- (2017) Pier Giorgio Cojutti et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Pharmacokinetics/pharmacodynamics of systemically administered polymyxin B against Klebsiella pneumoniae in mouse thigh and lung infection models
- (2017) Cornelia B Landersdorfer et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Effect of vancomycin initial dosing on time to systemic inflammatory response syndrome resolution in patients with methicillin-resistant Staphylococcus aureus bacteremia
- (2017) Jessica Lynn Wesolek et al. JOURNAL OF CHEMOTHERAPY
- Enterococcus faecalis and pathogenic streptococci inactivate daptomycin by releasing phospholipids
- (2017) Elizabeth V. K. Ledger et al. MICROBIOLOGY-SGM
- Recent advances and perspectives in the design and development of polymyxins
- (2017) Francesc Rabanal et al. NATURAL PRODUCT REPORTS
- Evaluation of Teicoplanin Trough Values After the Recommended Loading Dose in Children With Associated Safety Analysis
- (2017) Takaaki Yamada et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Daptomycin for Complicated Skin Infections: A Randomized Trial
- (2017) John Bradley et al. PEDIATRICS
- THPdb: Database of FDA-approved peptide and protein therapeutics
- (2017) Salman Sadullah Usmani et al. PLoS One
- Colistin Use in Patients With Reduced Kidney Function
- (2016) Enrico Fiaccadori et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Randomized Controlled Trial to Determine the Efficacy of Early Switch From Vancomycin to Vancomycin Alternatives as a Strategy to Prevent Nephrotoxicity in Patients With Multiple Risk Factors for Adverse Renal Outcomes (STOP-NT)
- (2016) Joseph J. Carreno et al. ANNALS OF PHARMACOTHERAPY
- Optimization of Polymyxin B in Combination with Doripenem To Combat Mutator Pseudomonas aeruginosa
- (2016) Neang S. Ly et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pharmacokinetics of Vancomycin in Elderly Patients Aged over 80 Years
- (2016) Laurent Bourguignon et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Multicenter Prospective Cohort Study of Renal Failure in Patients Treated with Colistin versus Polymyxin B
- (2016) Maria Helena Rigatto et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Optimizing the Clinical Use of Vancomycin
- (2016) Rocío Álvarez et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The action mechanism of daptomycin
- (2016) Scott D. Taylor et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Population pharmacokinetics of daptomycin in adult patients undergoing continuous renal replacement therapy
- (2016) Xiaoying Xu et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society
- (2016) Andre C. Kalil et al. CLINICAL INFECTIOUS DISEASES
- Vancomycin and the Risk of AKI: A Systematic Review and Meta-Analysis
- (2016) A. Sinha Ray et al. Clinical Journal of the American Society of Nephrology
- Daptomycin Pharmacokinetics and Pharmacodynamics in Septic and Critically Ill Patients
- (2016) Antonio D’Avolio et al. DRUGS
- Redeploying β-Lactams AgainstStaphylococcus aureus:Repurposing With a Purpose
- (2016) Arnold S. Bayer et al. JOURNAL OF INFECTIOUS DISEASES
- The effect of vancomycin powder on human dural fibroblast culture and its implications for dural repair during spine surgery
- (2016) Ezequiel Goldschmidt et al. JOURNAL OF NEUROSURGERY-SPINE
- Curcumin Attenuates Colistin-Induced Neurotoxicity in N2a Cells via Anti-inflammatory Activity, Suppression of Oxidative Stress, and Apoptosis
- (2016) Chongshan Dai et al. MOLECULAR NEUROBIOLOGY
- Daptomycin inhibits cell envelope synthesis by interfering with fluid membrane microdomains
- (2016) Anna Müller et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Augmented Renal Clearance in Patients With Febrile Neutropenia is Associated With Increased Risk for Subtherapeutic Concentrations of Vancomycin
- (2016) Keita Hirai et al. THERAPEUTIC DRUG MONITORING
- The evolution of antimicrobial peptide resistance in Pseudomonas aeruginosa is shaped by strong epistatic interactions
- (2016) Nicholas Jochumsen et al. Nature Communications
- Risk Factors for Non-Therapeutic Initial Steady-State Vancomycin Trough Concentrations in Children and Adolescents Receiving High Empiric Doses of Intravenous Vancomycin
- (2016) Whitney R. Buckel et al. PEDIATRIC DRUGS
- Approved Glycopeptide Antibacterial Drugs: Mechanism of Action and Resistance
- (2016) Daina Zeng et al. Cold Spring Harbor Perspectives in Medicine
- Therapeutic drug monitoring of anti-infective agents in critically ill patients
- (2016) Nynke G. L. Jager et al. Expert Review of Clinical Pharmacology
- Staphylococcus aureus inactivates daptomycin by releasing membrane phospholipids
- (2016) Vera Pader et al. Nature Microbiology
- Review of vancomycin-induced renal toxicity: an update
- (2016) Oluwatoyin Bamgbola Therapeutic Advances in Endocrinology and Metabolism
- Clinical Effectiveness, Safety Profile, and Pharmacokinetics of Daptomycin in Pediatric Patients: A Systematic Review
- (2016) Spyridon A. Karageorgos et al. Journal of the Pediatric Infectious Diseases Society
- Significant Accumulation of Polymyxin in Single Renal Tubular Cells: A Medicinal Chemistry and Triple Correlative Microscopy Approach
- (2015) Mohammad A. K. Azad et al. ANALYTICAL CHEMISTRY
- Major Pathways of Polymyxin-Induced Apoptosis in Rat Kidney Proximal Tubular Cells
- (2015) Mohammad A. K. Azad et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Clinical Outcomes Associated with Polymyxin B Dose in Patients with Bloodstream Infections Due to Carbapenem-Resistant Gram-Negative Rods
- (2015) Brian C. Nelson et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Mucin Binding Reduces Colistin Antimicrobial Activity
- (2015) Johnny X. Huang et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Impact of Glycopeptide Resistance in Staphylococcus aureus on the DalbavancinIn VivoPharmacodynamic Target
- (2015) A. Lepak et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Factors Impacting Unbound Vancomycin Concentrations in Different Patient Populations
- (2015) Matthijs Oyaert et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Updated US and European Dose Recommendations for Intravenous Colistin: How Do They Perform?
- (2015) Roger L. Nation et al. CLINICAL INFECTIOUS DISEASES
- Oritavancin: A Review in Acute Bacterial Skin and Skin Structure Infections
- (2015) Yahiya Y. Syed et al. DRUGS
- Intraventricular versus intravenous colistin for the treatment of extensively drug resistantAcinetobacter baumanniimeningitis
- (2015) P. De Bonis et al. EUROPEAN JOURNAL OF NEUROLOGY
- More accurate measurement of vancomycin minimum inhibitory concentration indicates poor outcomes in meticillin-resistant Staphylococcus aureus bacteraemia
- (2015) Hisashi Shoji et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Intravenous combined with aerosolised polymyxin versus intravenous polymyxin alone in the treatment of pneumonia caused by multidrug-resistant pathogens: a systematic review and meta-analysis
- (2015) Dong Liu et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Therapeutic Drug Monitoring of Daptomycin
- (2015) Claudine Reiber et al. THERAPEUTIC DRUG MONITORING
- Evaluation of Target Attainment of Vancomycin Area Under the Curve in Children With Methicillin-Resistant Staphylococcus Aureus Bacteremia
- (2015) Andrea Hahn et al. THERAPEUTIC DRUG MONITORING
- Interaction of the Antimicrobial Peptide Polymyxin B1 with Both Membranes of E. coli: A Molecular Dynamics Study
- (2015) Nils A. Berglund et al. PLoS Computational Biology
- Teaching ‘Old’ Polymyxins New Tricks: New-Generation Lipopeptides Targeting Gram-Negative ‘Superbugs’
- (2014) Tony Velkov et al. ACS Chemical Biology
- Innovative approaches to optimizing the delivery of vancomycin in individual patients
- (2014) Manjunath P. Pai et al. ADVANCED DRUG DELIVERY REVIEWS
- Comparison of Intrapulmonary and Systemic Pharmacokinetics of Colistin Methanesulfonate (CMS) and Colistin after Aerosol Delivery and Intravenous Administration of CMS in Critically Ill Patients
- (2014) Matthieu Boisson et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pulmonary and Systemic Pharmacokinetics of Inhaled and Intravenous Colistin Methanesulfonate in Cystic Fibrosis Patients: Targeting Advantage of Inhalational Administration
- (2014) S. W. S. Yapa et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In Vitro Assessment and Multicenter Cohort Study of Comparative Nephrotoxicity Rates Associated with Colistimethate versus Polymyxin B Therapy
- (2014) K. Phe et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Preliminary Study of Colistin versus Colistin plus Fosfomycin for Treatment of Carbapenem-Resistant Acinetobacter baumannii Infections
- (2014) Rujipas Sirijatuphat et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Exposure of Staphylococcus aureus to Subinhibitory Concentrations of β-Lactam Antibiotics Induces Heterogeneous Vancomycin-Intermediate Staphylococcus aureus
- (2014) Mélanie Roch et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Colistin-Induced Nephrotoxicity in Mice Involves the Mitochondrial, Death Receptor, and Endoplasmic Reticulum Pathways
- (2014) Chongshan Dai et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Treatment of gram - positive infections in critically ill patients
- (2014) Cristina Vazquez-Guillamet et al. BMC INFECTIOUS DISEASES
- Effectiveness of tigecycline-based versus colistin- based therapy for treatment of pneumonia caused by multidrug-resistant Acinetobacter baumanniiin a critical setting: a matched cohort analysis
- (2014) Yu-Chung Chuang et al. BMC INFECTIOUS DISEASES
- New Insights into Glycopeptide Antibiotic Binding to Cell Wall Precursors using SPR and NMR Spectroscopy
- (2014) Juan Treviño et al. CHEMISTRY-A EUROPEAN JOURNAL
- Colistin and Polymyxin B: Peas in a Pod, or Chalk and Cheese?
- (2014) R. L. Nation et al. CLINICAL INFECTIOUS DISEASES
- Global Prospective Epidemiologic and Surveillance Study of Ventilator-Associated Pneumonia due to Pseudomonas aeruginosa*
- (2014) Marin H. Kollef et al. CRITICAL CARE MEDICINE
- Intraventricular or intrathecal colistin for the treatment of central nervous system infections caused by multidrug-resistant Gram-negative bacteria
- (2014) Roberto Imberti et al. Expert Review of Anti-Infective Therapy
- Intrathecal/intraventricular colistin in external ventricular device-related infections by multi-drug resistant Gram negative bacteria: case reports and review
- (2014) O. Bargiacchi et al. INFECTION
- Glycopeptide antibiotics: Back to the future
- (2014) Mark S Butler et al. JOURNAL OF ANTIBIOTICS
- The Effect of Inoculum Size on Selection of In Vitro Resistance to Vancomycin, Daptomycin, and Linezolid in Methicillin-Resistant Staphylococcus aureus
- (2014) Laura Rio-Marques et al. Microbial Drug Resistance
- Role of Novel Multidrug Efflux Pump Involved in Drug Resistance in Klebsiella pneumoniae
- (2014) Vijaya Bharathi Srinivasan et al. PLoS One
- Vancomycin Dosing in Neutropenic Patients
- (2014) Michiel B. Haeseker et al. PLoS One
- Pharmacodynamic Characteristics of Nephrotoxicity Associated With Vancomycin Use in Children
- (2014) Jennifer Le et al. Journal of the Pediatric Infectious Diseases Society
- Risk Factors for Treatment Failure of Polymyxin B Monotherapy for Carbapenem-Resistant Klebsiella pneumoniae Infections
- (2013) Yanina Dubrovskaya et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Population Pharmacokinetics of Colistin Methanesulfonate in Rats: Achieving Sustained Lung Concentrations of Colistin for Targeting Respiratory Infections
- (2013) Shalini W. S. Yapa et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Effect of Pulmonary Surfactant on Antimicrobial ActivityIn Vitro
- (2013) R. Schwameis et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Unique Structural Modifications Are Present in the Lipopolysaccharide from Colistin-Resistant Strains of Acinetobacter baumannii
- (2013) Mark R. Pelletier et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Inoculum Effects of Ceftobiprole, Daptomycin, Linezolid, and Vancomycin with Staphylococcus aureus and Streptococcus pneumoniae at Inocula of 105and 107CFU Injected into Opposite Thighs of Neutropenic Mice
- (2013) Dong-Gun Lee et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pharmacokinetics of Colistin Methanesulfonate and Formed Colistin in End-Stage Renal Disease Patients Receiving Continuous Ambulatory Peritoneal Dialysis
- (2013) Pornpan Koomanachai et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Vancomycin AUC/MIC Ratio and 30-Day Mortality in Patients with Staphylococcus aureus Bacteremia
- (2013) Natasha E. Holmes et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Nephrotoxicity and Efficacy Assessment of Polymyxin Use in 92 Transplant Patients
- (2013) Marcelo M. Mostardeiro et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Combined Intravenous and Intraventricular Administration of Colistin Methanesulfonate in Critically Ill Patients with Central Nervous System Infection
- (2013) Mairi Ziaka et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Are Vancomycin Trough Concentrations Adequate for Optimal Dosing?
- (2013) Michael N. Neely et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Polymyxin B Induces Apoptosis in Kidney Proximal Tubular Cells
- (2013) Mohammad A. K. Azad et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Development of Initial Loading Procedure for Teicoplanin in Critically Ill Patients with Severe Infections
- (2013) Kazuaki Matsumoto et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- Trough colistin plasma level is an independent risk factor for nephrotoxicity: a prospective observational cohort study
- (2013) Luisa Sorlí et al. BMC INFECTIOUS DISEASES
- Effect of Aerosolized Colistin as Adjunctive Treatment on the Outcomes of Microbiologically Documented Ventilator-Associated Pneumonia Caused by Colistin-Only Susceptible Gram-Negative Bacteria
- (2013) Mario Tumbarello et al. CHEST
- Population Pharmacokinetics of Intravenous Polymyxin B in Critically Ill Patients: Implications for Selection of Dosage Regimens
- (2013) Ana M. Sandri et al. CLINICAL INFECTIOUS DISEASES
- Antimicrobial Treatment of Febrile Neutropenia: Pharmacokinetic–Pharmacodynamic Considerations
- (2013) Tiphaine Goulenok et al. CLINICAL PHARMACOKINETICS
- A Stewardship Program’s Retrospective Evaluation of Vancomycin AUC24/MIC and Time to Microbiological Clearance in Patients with Methicillin-Resistant Staphylococcus aureus Bacteremia and Osteomyelitis
- (2013) Kristen M. Gawronski et al. CLINICAL THERAPEUTICS
- The current spectrum of infection in cancer patients with chemotherapy related neutropenia
- (2013) Lior Nesher et al. INFECTION
- Surface changes and polymyxin interactions with a resistant strain of Klebsiella pneumoniae
- (2013) Tony Velkov et al. Innate Immunity
- Risk factors for acute kidney injury in patients treated with polymyxin B or colistin methanesulfonate sodium
- (2013) Felipe F. Tuon et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Population pharmacokinetic and pharmacodynamic analyses of teicoplanin in Japanese patients with systemic MRSA infection
- (2013) Ryuichi Ogawa et al. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
- Lung and Serum Teicoplanin Concentration After Aerosol and Intravenous Administration in a Rat Model
- (2013) Emmanuelle Mercier et al. Journal of Aerosol Medicine and Pulmonary Drug Delivery
- A secondary mode of action of polymyxins against Gram-negative bacteria involves the inhibition of NADH-quinone oxidoreductase activity
- (2013) Zakuan Z Deris et al. JOURNAL OF ANTIBIOTICS
- A validated ultra-performance liquid chromatography-tandem mass spectrometry method for the quantification of polymyxin B in mouse serum and epithelial lining fluid: application to pharmacokinetic studies
- (2013) J. He et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Unbound fraction of vancomycin in intensive care unit patients
- (2013) Martin G. Kees et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Variability of pharmacokinetic parameters in patients receiving different dosages of daptomycin: is therapeutic drug monitoring necessary?
- (2013) Marco Falcone et al. JOURNAL OF INFECTION AND CHEMOTHERAPY
- Practice guidelines for therapeutic drug monitoring of vancomycin: a consensus review of the Japanese Society of Chemotherapy and the Japanese Society of Therapeutic Drug Monitoring
- (2013) Kazuaki Matsumoto et al. JOURNAL OF INFECTION AND CHEMOTHERAPY
- Alternative Mutational Pathways to Intermediate Resistance to Vancomycin in Methicillin-Resistant Staphylococcus aureus
- (2013) Celine Vidaillac et al. JOURNAL OF INFECTIOUS DISEASES
- Evaluation of heteroresistance to polymyxin B among carbapenem-susceptible and -resistant Pseudomonas aeruginosa
- (2013) D. M. Hermes et al. JOURNAL OF MEDICAL MICROBIOLOGY
- Teicoplanin as an Effective Alternative to Vancomycin for Treatment of MRSA Infection in Chinese Population: A Meta-analysis of Randomized Controlled Trials
- (2013) Yang Peng et al. PLoS One
- Global survey of polymyxin use: A call for international guidelines
- (2013) Heiman Wertheim et al. Journal of Global Antimicrobial Resistance
- Redesign of Glycopeptide Antibiotics: Back to the Future
- (2012) Robert C. James et al. ACS Chemical Biology
- Rapid Killing of Acinetobacter baumannii by Polymyxins Is Mediated by a Hydroxyl Radical Death Pathway
- (2012) Timothy R. Sampson et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Application of a Loading Dose of Colistin Methanesulfonate in Critically Ill Patients: Population Pharmacokinetics, Protein Binding, and Prediction of Bacterial Kill
- (2012) Ami F. Mohamed et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Systematic Review and Meta-Analysis of Vancomycin-Induced Nephrotoxicity Associated with Dosing Schedules That Maintain Troughs between 15 and 20 Milligrams per Liter
- (2012) S. J. van Hal et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pharmacokinetics of Colistin in Cerebrospinal Fluid after Intraventricular Administration of Colistin Methanesulfonate
- (2012) Roberto Imberti et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The Combination of Colistin and Doripenem Is Synergistic against Klebsiella pneumoniae at Multiple Inocula and Suppresses Colistin Resistance in anIn VitroPharmacokinetic/Pharmacodynamic Model
- (2012) Zakuan Z. Deris et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pharmacokinetics and Renal Disposition of Polymyxin B in an Animal Model
- (2012) Kamilia Abdelraouf et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In VivoPharmacokinetics/Pharmacodynamics of Colistin and Imipenem in Pseudomonas aeruginosa Biofilm Infection
- (2012) Wang Hengzhuang et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Novel pharmaceutical molecules against emerging resistant gram-positive cocci
- (2012) Roberto Manfredi et al. Brazilian Journal of Infectious Diseases
- Is Peak Concentration Needed in Therapeutic Drug Monitoring of Vancomycin? A Pharmacokinetic-Pharmacodynamic Analysis in Patients with Methicillin-ResistantStaphylococcus aureusPneumonia
- (2012) Yosuke Suzuki et al. CHEMOTHERAPY
- Polymyxin Use Associated With Respiratory Arrest
- (2012) Hannah Wunsch et al. CHEST
- In Vivo Activity of Oritavancin in Animal Infection Models and Rationale for a New Dosing Regimen in Humans
- (2012) P. G. Ambrose et al. CLINICAL INFECTIOUS DISEASES
- Pharmacokinetics and pharmacodynamics of ‘old’ polymyxins: what is new?
- (2012) Phillip J. Bergen et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Colistin vs. the combination of colistin and rifampicin for the treatment of carbapenem-resistant Acinetobacter baumannii ventilator-associated pneumonia
- (2012) H. AYDEMIR et al. EPIDEMIOLOGY AND INFECTION
- Comparison of polymyxin B with other antimicrobials in the treatment of ventilator-associated pneumonia and tracheobronchitis caused by Pseudomonas aeruginosa or Acinetobacter baumannii
- (2012) M. H. Rigatto et al. INFECTION
- Pharmacokinetics of inhaled colistimethate sodium (CMS) in mechanically ventilated critically ill patients
- (2012) Zoe E. Athanassa et al. INTENSIVE CARE MEDICINE
- Activity of oritavancin against methicillin-resistant staphylococci, vancomycin-resistant enterococci and -haemolytic streptococci collected from western European countries in 2011
- (2012) I. Morrissey et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Twenty-five years of shared life with vancomycin-resistant enterococci: is it time to divorce?
- (2012) V. Cattoir et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Use of high-dose IV and aerosolized colistin for the treatment of multidrug-resistant Acinetobacter baumannii ventilator-associated pneumonia: do we really need this treatment?
- (2012) Gamze Kalin et al. JOURNAL OF INFECTION AND CHEMOTHERAPY
- Daptomycin: A Review of Properties, Clinical Use, Drug Delivery and Resistance
- (2012) C. Vilhena et al. MINI-REVIEWS IN MEDICINAL CHEMISTRY
- Drug Dosing Based on Weight and Body Surface Area: Mathematical Assumptions and Limitations in Obese Adults
- (2012) Manjunath P. Pai PHARMACOTHERAPY
- Prevalence and clinical outcomes of episodes of ventilator-associated pneumonia caused by SPM-1-producing and non-producing imipenem-resistant Pseudomonas aeruginosa
- (2012) Guilherme Henrique Campos Furtado et al. Revista da Sociedade Brasileira de Medicina Tropical
- Evaluation of Novel Acute Urinary Rat Kidney Toxicity Biomarker for Subacute Toxicity Studies in Preclinical Trials
- (2012) Tobias Christian Fuchs et al. TOXICOLOGIC PATHOLOGY
- Penetration of Vancomycin into Epithelial Lining Fluid in Healthy Volunteers
- (2011) Thomas P. Lodise et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Oritavancin Activity against Vancomycin-Susceptible and Vancomycin-Resistant Enterococci with Molecularly Characterized Glycopeptide Resistance Genes Recovered from Bacteremic Patients, 2009-2010
- (2011) Rodrigo E. Mendes et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Refining Vancomycin Protein Binding Estimates: Identification of Clinical Factors That Influence Protein Binding
- (2011) Jill M. Butterfield et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Vancomycin AUC24/MIC Ratio in Patients with Complicated Bacteremia and Infective Endocarditis Due to Methicillin-Resistant Staphylococcus aureus and Its Association with Attributable Mortality during Hospitalization
- (2011) Jack Brown et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Reduction in Membrane Phosphatidylglycerol Content Leads to Daptomycin Resistance in Bacillus subtilis
- (2011) Anna-Barbara Hachmann et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Population Pharmacokinetics of Colistin Methanesulfonate and Formed Colistin in Critically Ill Patients from a Multicenter Study Provide Dosing Suggestions for Various Categories of Patients
- (2011) S. M. Garonzik et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Recent advances in the synthesis of new glycopeptide antibiotics
- (2011) Polly-Anna Ashford et al. CHEMICAL SOCIETY REVIEWS
- Vancomycin: We Can't Get There From Here
- (2011) N. Patel et al. CLINICAL INFECTIOUS DISEASES
- Impact of Vancomycin Exposure on Outcomes in Patients With Methicillin-Resistant Staphylococcus aureus Bacteremia: Support for Consensus Guidelines Suggested Targets
- (2011) R. Kullar et al. CLINICAL INFECTIOUS DISEASES
- Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance
- (2011) A.-P. Magiorakos et al. CLINICAL MICROBIOLOGY AND INFECTION
- Pharmacokinetics of Colistin and Colistimethate Sodium After a Single 80-mg Intravenous Dose of CMS in Young Healthy Volunteers
- (2011) W Couet et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Safety and pharmacokinetic evaluation of intravenous colistin methanesulfonate sodium in Japanese healthy male subjects
- (2011) Kaori Mizuyachi et al. CURRENT MEDICAL RESEARCH AND OPINION
- Activity of tigecycline alone and in combination with colistin and meropenem against Klebsiella pneumoniae carbapenemase (KPC)-producing Enterobacteriaceae strains by time–kill assay
- (2011) Spyros Pournaras et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Exploration of optimal teicoplanin dosage based on pharmacokinetic parameters for the treatment of intensive care unit patients infected with methicillin-resistant Staphylococcus aureus
- (2011) Mao Hagihara et al. JOURNAL OF INFECTION AND CHEMOTHERAPY
- Teicoplanin Dosing Strategy for Treatment ofStaphylococcus aureusin Korean Patients with Neutropenic Fever
- (2011) Byung-Jin Ahn et al. YONSEI MEDICAL JOURNAL
- Pharmacodynamics of Telavancin Studied in anIn VitroPharmacokinetic Model of Infection
- (2010) Alasdair P. MacGowan et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Attenuation of Colistin Bactericidal Activity by High Inoculum of Pseudomonas aeruginosa Characterized by a New Mechanism-Based Population Pharmacodynamic Model
- (2010) J. B. Bulitta et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Assay of Colistin and Colistin Methanesulfonate in Plasma and Urine by Liquid Chromatography-Tandem Mass Spectrometry
- (2010) P. Gobin et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Oritavancin Disrupts Membrane Integrity of Staphylococcus aureus and Vancomycin-Resistant Enterococci To Effect Rapid Bacterial Killing
- (2010) A. Belley et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Colistin Resistance in Acinetobacter baumannii Is Mediated by Complete Loss of Lipopolysaccharide Production
- (2010) J. H. Moffatt et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Postantibiotic Effects of Tigecycline, Colistin Sulfate, and Levofloxacin Alone or Tigecycline-Colistin Sulfate and Tigecycline-Levofloxacin Combinations against Acinetobacter baumannii
- (2010) Berna Özbek et al. CHEMOTHERAPY
- Steady-State Pharmacokinetics and BAL Concentration of Colistin in Critically Ill Patients After IV Colistin Methanesulfonate Administration
- (2010) Roberto Imberti et al. CHEST
- Intravenous and Inhalational Colistin–Induced Respiratory Failure
- (2010) Krista Wahby et al. CLINICAL INFECTIOUS DISEASES
- Pharmacodynamic comparison of linezolid, teicoplanin and vancomycin against clinical isolates of Staphylococcus aureus and coagulase-negative staphylococci collected from hospitals in Brazil
- (2010) J.L. Kuti et al. CLINICAL MICROBIOLOGY AND INFECTION
- Reduced Vancomycin Susceptibility in Staphylococcus aureus, Including Vancomycin-Intermediate and Heterogeneous Vancomycin-Intermediate Strains: Resistance Mechanisms, Laboratory Detection, and Clinical Implications
- (2010) B. P. Howden et al. CLINICAL MICROBIOLOGY REVIEWS
- The importance of tissue penetration in achieving successful antimicrobial treatment of nosocomial pneumonia and complicated skin and soft-tissue infections caused by methicillin-resistantStaphylococcus aureus: vancomycin and linezolid
- (2010) Gary E. Stein et al. CURRENT MEDICAL RESEARCH AND OPINION
- New Lipoglycopeptides
- (2010) George G. Zhanel et al. DRUGS
- Variability of polymyxin B major components in commercial formulations
- (2010) Jie He et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Dose-ranging pharmacokinetics of colistin methanesulphonate (CMS) and colistin in rats following single intravenous CMS doses
- (2010) S. Marchand et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- An initial dosing method for teicoplanin based on the area under the serum concentration time curve required for MRSA eradication
- (2010) Naoko Kanazawa et al. JOURNAL OF INFECTION AND CHEMOTHERAPY
- Kidney injury molecule-1 outperforms traditional biomarkers of kidney injury in preclinical biomarker qualification studies
- (2010) Vishal S Vaidya et al. NATURE BIOTECHNOLOGY
- Neurotoxicity in patients treated with intravenous polymyxin B: Two case reports
- (2009) L. Weinstein et al. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
- Activity of Telavancin against Staphylococci and Enterococci Determined by MIC and Resistance Selection Studies
- (2009) K. Kosowska-Shick et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Renal Disposition of Colistin in the Isolated Perfused Rat Kidney
- (2009) Z. Ma et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Comparative Efficacy and Safety of Vancomycin versus Teicoplanin: Systematic Review and Meta-Analysis
- (2009) S. Svetitsky et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Oritavancin Population Pharmacokinetics in Healthy Subjects and Patients with Complicated Skin and Skin Structure Infections or Bacteremia
- (2009) C. M. Rubino et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- VanA-Type Vancomycin-Resistant Staphylococcus aureus
- (2009) B. Perichon et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Involvement of pmrAB and phoPQ in Polymyxin B Adaptation and Inducible Resistance in Non-Cystic Fibrosis Clinical Isolates of Pseudomonas aeruginosa
- (2009) K. N. Schurek et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Influence of the Charge State on the Structures and Interactions of Vancomycin Antibiotics with Cell-Wall Analogue Peptides: Experimental and Theoretical Studies
- (2009) Zhibo Yang et al. CHEMISTRY-A EUROPEAN JOURNAL
- Telavancin: A Novel Lipoglycopeptide
- (2009) Louis D. Saravolatz et al. CLINICAL INFECTIOUS DISEASES
- Initial Low‐Dose Gentamicin forStaphylococcus aureusBacteremia and Endocarditis Is Nephrotoxic
- (2009) Sara E. Cosgrove et al. CLINICAL INFECTIOUS DISEASES
- Daptomycin: mechanisms of action and resistance, and biosynthetic engineering
- (2009) Richard H Baltz CURRENT OPINION IN CHEMICAL BIOLOGY
- Polymyxin B and colistimethate are comparable as to efficacy and renal toxicity
- (2009) Maura S. Oliveira et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Pharmacokinetics and Pharmacodynamics of Antibacterial Agents
- (2009) Matthew E. Levison et al. INFECTIOUS DISEASE CLINICS OF NORTH AMERICA
- Vancomycin and Oritavancin Have Different Modes of Action in Enterococcus faecium
- (2009) Gary J. Patti et al. JOURNAL OF MOLECULAR BIOLOGY
- Therapeutic monitoring of vancomycin in adult patients: A consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists
- (2008) M. Rybak et al. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
- Infectious Diseases: Parenteral Polymyxin B Use in Patients with Multidrug-Resistant Gram-Negative Bacteremia and Urinary Tract Infections: A Retrospective Case Series
- (2008) Andrew A Pastewski et al. ANNALS OF PHARMACOTHERAPY
- Telavancin Penetration into Human Epithelial Lining Fluid Determined by Population Pharmacokinetic Modeling and Monte Carlo Simulation
- (2008) T. P. Lodise et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Larger Vancomycin Doses (at Least Four Grams per Day) Are Associated with an Increased Incidence of Nephrotoxicity
- (2008) T. P. Lodise et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Oritavancin Kills Stationary-Phase and Biofilm Staphylococcus aureus Cells In Vitro
- (2008) A. Belley et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pharmacokinetics of Intravenous Polymyxin B in Critically Ill Patients
- (2008) Alexandre P. Zavascki et al. CLINICAL INFECTIOUS DISEASES
- Colistin serum concentrations after intravenous administration in critically ill patients with serious multidrug-resistant, gram-negative bacilli infections: A prospective, open-label, uncontrolled study
- (2008) Nikolaos Markou et al. CLINICAL THERAPEUTICS
- Dalbavancin and telavancin: novel lipoglycopeptides for the treatment of Gram-positive infections
- (2008) George G Zhanel et al. Expert Review of Anti-Infective Therapy
- In vitro pharmacodynamics of colistin against multidrug-resistant Klebsiella pneumoniae
- (2008) A. Poudyal et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Pharmacodynamics and pharmacokinetics of antibacterial drugs in the management of febrile neutropenia
- (2008) Olivier Lortholary et al. LANCET INFECTIOUS DISEASES
- Tolerance to the antimicrobial peptide colistin in Pseudomonas aeruginosa biofilms is linked to metabolically active cells, and depends on the pmr and mexAB-oprM genes
- (2008) Sünje Johanna Pamp et al. MOLECULAR MICROBIOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More